Carolina Abramovitch

Title: Carolina Abramovitch: Innovator in Interferon Research

Introduction

Carolina Abramovitch is a notable inventor based in Yavne, Israel. She has made significant contributions to the field of interferon research, particularly through her innovative work on proteins that interact with the type I interferon receptor.

Latest Patents

Carolina Abramovitch holds 2 patents related to her research on IFN receptor 1 binding proteins. Her latest patents focus on novel proteins IR1B1 and IR1B4, which have been isolated to bind to the type I IFN receptor IFNAR1. These proteins play a crucial role in the cellular response to interferons (IFNs). The DNA encoding these proteins can be administered in either the sense or anti-sense orientation to enhance or inhibit the cellular response to IFNs. Additionally, antibodies to these proteins can be utilized for the isolation of the new proteins or for immunodetection purposes.

Career Highlights

Carolina Abramovitch is associated with Yeda Research and Development Co. Ltd., where she continues to advance her research in the field of interferon biology. Her work has implications for therapeutic strategies in various diseases.

Collaborations

Some of her notable coworkers include Michel Revel and Judith Chebath, who have also contributed to the field of interferon research.

Conclusion

Carolina Abramovitch's innovative work in the area of interferon receptor binding proteins highlights her significant role in advancing scientific knowledge and potential therapeutic applications. Her contributions are paving the way for future research in this important area of medicine.